Thomas Kraut was told he was just fat until doctors discovered a massive tumor in his belly. Doctors were convinced that a Norwegian man was simply fat for 12 years — but his growing belly was ...

Tenosynovial giant cell tumor (TGCT) is a group of rare tumors. They are usually benign (not cancer) and tend to occur in people between 25 to 50 years old. The tumors affect areas of the joints and ...

A mom-of-four had an orange-sized tumor removed from her jaw - after being spotted at the side of the road by surgeons passing through her village. Marie Elisa, 45, had been living with the benign ...

MEXICO CITY — Mexican doctors say they have removed a 130-pound (60-kilogram) tumor from the body of a 51-year-old woman who had been unable to leave her home for two years. Dr. Gilberto Inzulza says ...

Romvimza is a medicine called a kinase inhibitor that is used to treat tenosynovial giant cell tumor (TGCT) that may be made worse by surgery. TGCT is a condition where tumors form in joints of the ...

Emactuzumab has received FDA fast track designation for TGCT treatment, aiding development for conditions lacking effective options. The phase 3 TANGENT trial evaluates emactuzumab, a CSF-1R ...

Dr. William Tap led the development of vimseltinib for tenosynovial giant cell tumor. The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare ...

Two-team surgical approach removes more complex pituitary tumors, reduces bleeding risk, and lowers recurrence compared to traditional endonasal surgery Two-team surgical approach removes more complex ...